Rare Kidney Diseases Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Rare Kidney Diseases Market is Segmented By Target Disease Indications (Fabry Disease, Lupus Nephritis, Focal Segmental Glomerulosclerosis, Atypical Hemolytic Uremic Syndrome, Immunoglobulin A Nephropathy), By Molecule Type (Biologics, Small Molecules), By Route of Administration (Oral, Parentral), By Therapy (Monotherapy, Combination Therapy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Rare Kidney Diseases Market Leaders

  • Seres Therapeutics, Inc.
  • Enterome
  • 4D pharma plc
  • International Flavors & Fragrances Inc.
  • OptiBiotix Health Plc
*Disclaimer: Major players are listed in no particular order.

Rare Kidney Diseases Market - Company List

  • Seres Therapeutics, Inc.
  • Enterome
  • 4D pharma plc
  • International Flavors & Fragrances Inc.
  • OptiBiotix Health Plc
  • Ferring Pharmaceuticals
  • Synlogic, Inc.
  • Second Genome, Inc.
  • Vedanta Biosciences, Inc.
  • YSOPIA Bioscience
  • FlightPath Biosciences, Inc.
  • Finch Therapeutics Group, Inc.
  • AOBiome Therapeutics
  • BioGaia
  • Quantbiome, Inc.
  • Viome Life Sciences, Inc.
  • BIOHM Health
  • DayTwo
  • Atlas Biomed
  • Gnubiotics Sciences

Rare Kidney Diseases Market Report Snapshots

Buy Now